<DOC>
	<DOC>NCT00312312</DOC>
	<brief_summary>The purpose of this study is to evaluate the immunomodulatory effect of treatment of allergic rhinitis symptoms with specific immunotherapy by measurement of pulmonary inflammatory markers, and among others, exhaled nitric oxide.</brief_summary>
	<brief_title>Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Hypersensitivity, Immediate</mesh_term>
	<criteria>Age 1845 years old Skin prick test or RAS test and physical examination conclude that the patient will have a beneficial effect from specific immunotherapy Other diseases except atopic disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Atopy</keyword>
	<keyword>Exhaled nitric oxide</keyword>
	<keyword>Specific immunotherapy</keyword>
	<keyword>Atopic diseases</keyword>
</DOC>